​

NGM Biopharmaceuticals Ownership | Who Owns NGM Biopharmaceuticals?

OverviewForecastRevenueFinancialsChart

NGM Biopharmaceuticals Ownership Summary

NGM Biopharmaceuticals is owned by 41.82% institutional investors, and 58.18% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of NGM shares. Fidelity Small Cap Index is the top mutual fund, with 0.52% of its assets in NGM Biopharmaceuticals shares.

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Legal & general group---
Stepstone group lp---
Diker management---
Renaissance---
Strs ohio---
Trium capital llp---
Engineers gate manager lp---
Gsa capital partners llp---
Price t rowe associates inc /md/---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Legal & general group---
Stepstone group lp---
Diker management---
Renaissance---
Strs ohio---
Trium capital llp---
Engineers gate manager lp---
Gsa capital partners llp---
Price t rowe associates inc /md/---

Top Buyers

HolderShares% AssetsChange
Nelson, van denburg & campbell wealth management group---7.00
Nisa investment advisors---75.00
Farther finance advisors---96.00
Citadel advisors---200.00
Gamma investing---346.00

Top Sellers

HolderShares% AssetsChange
Column group---18.14M
Blackrock---3.00M
Vanguard group---2.32M
Stepstone group lp---1.57M
Euclidean capital---992.17K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Nisa investment advisors-75.00
Farther finance advisors-96.00
Citadel advisors-200.00
Gamma investing-346.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202474-10.84%34,628,446-15.79%411.69%30-11.76%27-20.59%
Dec 31, 202383-10.75%41,123,369-12.96%491.51%34-20.93%34-
Sep 30, 202393-10.58%47,244,554-1.52%571.67%43-14.00%34-8.11%
Jun 30, 2023104-16.13%47,971,646-1.55%581.66%50-12.28%37-15.91%
Mar 31, 2023124-0.80%48,728,228-1.63%591.55%57-31.33%4491.30%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Small Cap Index433.89K0.52%-6.54K
BlackRock Extended Equity Market K136.38K0.16%58.04K
NT R2000 Index Fund - NL115.05K0.14%12.87K
NT R2000 Value Index Fund - NL102.91K0.12%-32.62K
Russell 2000 Index Non-Lendable Fund E101.87K0.12%-10.23K
NT R2000 Index Fund - DC - NL - 291.36K0.11%10.90K
BlackRock Extended Mkt Composite91.08K0.11%763.00
NT R2000 Value Index Fund - L84.65K0.10%-
Northern Trust Russell 2000 Value Index84.65K0.10%-
BlackRock Russell 2500™ Index F67.07K0.08%28.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 15, 2023COLUMN GROUP L P Buy$11.88K
Nov 16, 2023COLUMN GROUP L P Buy$3.63K
Nov 16, 2023COLUMN GROUP L P Buy$3.63K
Nov 15, 2023COLUMN GROUP L P Buy$11.88K
Nov 16, 2023COLUMN GROUP L P Buy$3.63K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q410-
2023 Q3--
2023 Q2--
2023 Q1321

NGM Ownership FAQ

Who owns the most shares of NGM Biopharmaceuticals?

NGM Biopharmaceuticals’s largest shareholders are Geode capital management (0 shares, 0%), Legal & general group (0 shares, 0%), and Stepstone group lp (0 shares, 0%). Together, they hold 0% of NGM Biopharmaceuticals’s total shares outstanding.

Does Blackrock own NGM Biopharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NGM Biopharmaceuticals.

Who is NGM Biopharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is NGM Biopharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 NGM Biopharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of NGM Biopharmaceuticals shares?

Fidelity Small Cap Index is the top mutual fund holder of NGM Biopharmaceuticals shares, with 0.52% of its total shares outstanding invested in 433.89K NGM Biopharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools